Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01680263

Enrollment

Registered

2012-09-07

Start date

2012-02-29

Completion date

2012-07-31

Last updated

2012-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pes Anserinus Tendinobursitis

Keywords

Kinesiotaping, pes anserinus tendino-bursitis, nonsteroidal anti-inflammatory drugs, physical therapy

Brief summary

The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.

Detailed description

The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.

Interventions

DEVICEKinesiotaping

Use of kinesiotaping on the painful area in the form of space correction. Kinesiotaping was repeated for 3 weeks with 1week interval

PROCEDURENSAIDs/Physical therapy

Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Patients with clinical diagnosis of pes anserinus tendino-bursitis.

Exclusion criteria

* Previous history of trauma or surgery on the knee joint, * History of NSAIDs induced acid-peptic disease * Systemic and rheumatic diseases

Design outcomes

Primary

Measure	Time frame	Description
Pain (VAS)and swelling scores	3 weeks	Visual analog scale for pain evaluation Assessment of the local swelling via palpation

Secondary

Measure	Time frame	Description
The number of participants with adverse events	3 weeks	The number of participants with adverse events

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026